Regulations
EUAs for rare disease advanced therapies? Not likely, says FDA
RegulationsEUAs for rare disease advanced therapies? Not likely, says FDAEUAs for rare disease advanced therapies? Not likely, says FDA
The FDA has dismissed using EUAs for rare disease advanced therapeutics but does hope to significantly speed up its feedback to sponsors.